TD Cowen Downgrades RXO to Sell, Lowers Price Target to $19

Benzinga Newsdesk www.benzinga.com Negative 90.2%

Neg 90.2% Neu 0% Pos 0%

TD Cowen analyst Jason Seidl downgrades RXO (NYSE:RXO) from Hold to Sell and lowers the price target from $24 to $19.

Comments

No comments yet. Be the first!